Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 4/20 | 0.56 |
| ▸ | PSEN1 | P49768 | 6/20 | 0.49 |
| ▸ | PSEN2 | P49810 | 6/20 | 0.49 |
| ▸ | APH1B | Q8WW43 | 6/20 | 0.49 |
| ▸ | NCSTN | Q92542 | 6/20 | 0.49 |
| ▸ | APH1A | Q96BI3 | 6/20 | 0.49 |
| ▸ | PSENEN | Q9NZ42 | 6/20 | 0.49 |
| ▸ | CNR2 | P34972 | 7/20 | 0.48 |
| ▸ | RORA | P35398 | 1/20 | 0.45 |
| ▸ | RORC | P51449 | 1/20 | 0.45 |
| ▸ | RORB | Q92753 | 1/20 | 0.45 |
| ▸ | CNR1 | P21554 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6279820 | 1.00 | PTGER4 (0.56) | PTGER4PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL851318 | 1.00 | PTGER4 (0.56) | PTGER4PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL29794198 | 1.00 | PTGER4 (0.56) | PTGER4PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL29794182 | 1.00 | PTGER4 (0.56) | PTGER4PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL6281257 | 1.00 | PTGER4 (0.56) | PTGER4PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL6275738 | 1.00 | PTGER4 (0.56) | PTGER4PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL29808759 | 1.00 | PTGER4 (0.56) | PTGER4PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL28615487 | 1.00 | PTGER4 (0.56) | PTGER4PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL6279947 | 1.00 | PTGER4 (0.56) | PTGER4PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL28320942 | 1.00 | PTGER4 (0.56) | PTGER4PSEN1PSEN2APH1BNCSTN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6835513-B2 | An organophotoreceptor comprising: (a) a charge transport compound having the formula carbazole compound dispersion of colorant particles in an organic liquid and charge transport compound having the formula of carbazole compound | SAMSUNG ELECTRONIC CO., LTD. (KR) | 2004-12-28 | — | — | US | disclosed |
| US-20030207188-A1 | Carbazole based charge transport compounds | S-PRINTING SOLUTION CO., LTD. (KR) | 2003-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030207188-A1 | Carbazole based charge transport compounds | SLC33A1, SLC43A1, AHR | PTGER4 1331/4885PSEN1 4221/4885PSEN2 4114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.